CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

DTILPRECISION BIOSCIENCES INC

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $6.26 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$172.79M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-30 · Frankel Stanley (Director) · BUY
  • 2026-09-29 · Brown Melinda (Director) · BUY
  • 2026-09-29 · Germano Geno J (Director) · BUY
  • 2026-05-22 · Germano Geno J (Director) · OTHER
  • 2026-05-22 · Frankel Stanley (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders100
Shares held19,445,408
Value$144.48M
Percent of shares outstanding70.45%
As of quarter end2026-06-30
RECENT NEWS
  • Precision Biosciences director Geno Germano buys $16,384 in stock
  • Precision Biosciences director Melinda Brown buys $7,116 in stock
  • Precision BioSciences presents two programs at H.C. Wainwright conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
PRECISION BIOSCIENCES INC (DTIL) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit